DRUG · Mapped RxNorm record
Cilostazol
Normalized identity: cilostazolView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Cilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
NCT07719894
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Aspirin
Normalized identity: aspirinView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedCilostazol and Aspirin for Cardiovascular Event Prevention in Patients With Type 2 Diabetes
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Type 2 Diabetes Mellitus (T2DM)unresolved
Atherosclerosisverified · MONDO: atherosclerosis
Interventions
CilostazolDRUG · verified · RxNorm: cilostazol
AspirinDRUG · verified · RxNorm: aspirin
Sponsors & collaborators
Seoul National University Bundang Hospitallead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07719894 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.